PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31892132-5	2019	Therefore, we investigated the effect of beta-caryophyllene (BCP), a CB2-selective phytocannabinoid, in a model of NRTI-induced neuropathic pain.	phytocannabinoid	83-99	cannabinoid receptor 2 (macrophage)	Mus musculus	69-72	
28368293-0	2017	(-)-beta-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.	phytocannabinoid	49-65	cannabinoid receptor 2 (macrophage)	Mus musculus	26-29	
28368293-1	2017	(-)-beta-caryophyllene (BCP), a cannabinoid receptor type 2 (CB2)-selective phytocannabinoid, has already been shown in precedent literature to exhibit both anti-inflammatory and analgesic effects in mouse models of inflammatory and neuropathic pain.	phytocannabinoid	76-92	cannabinoid receptor 2 (macrophage)	Mus musculus	61-64	
24210682-0	2014	The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.	phytocannabinoid	39-55	cannabinoid receptor 2 (macrophage)	Mus musculus	16-19